Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium Animalis Subsp. Lactis as an Adjunct to Phototherapy in Indirect Hyperbilirubinemia
NCT07773012Not yet recruiting
- Sponsor
- Can Tho University of Medicine and Pharmacy
- Start
- Aug 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised trial of bifidobacterium animalis lactis in hyperbilirubinemia (2 arms), sponsored by Can Tho University of Medicine and Pharmacy. Primary endpoints: Duration of phototherapy and Change in serum total bilirubin level at day 3. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
bifidobacterium animalis lactis
03
Conditions
hyperbilirubinemia
Beyond the preview
Go deeper on NCT07773012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07773012.